9mg is the third strength in the UK Wegovy pill dose ladder. Its public availability status changes on the planned 20 July 2026 launch date, so a launch page or waitlist should not be confused with an orderable listing.
Where 9mg fits in the dose ladder
The approved Wegovy tablet schedule has four strengths: 1.5mg, 4mg, 9mg and 25mg. The leaflet places 9mg after the two lower monthly stages. That sequence describes the medicine’s licensed schedule; it does not tell any individual when to change dose or whether a higher strength is appropriate.
Once 9mg is live, comparison should focus on the published standard price for that strength and the provider’s full terms. A lower first-order figure, a subscription commitment or a bundled consultation should not be compared as though it were the ordinary monthly price.
UK availability status
Current provider listings are available to compare. 9mg has 37 current standard-price rows in the price feed. Stock, eligibility and final terms can still vary, so check the provider page before ordering.
See the current Wegovy pill availability overview.
Why the official leaflet matters
Wegovy tablets have specific administration instructions that affect absorption. The product leaflet covers fasting, water, food, other oral medicines, missed doses and safety warnings. A provider’s launch copy is not a substitute for the leaflet supplied with a prescription.
Read the official Wegovy tablets patient information leaflet.
Safety and follow-up
Speak to the prescribing service, pharmacist or GP about symptoms that are troublesome or persistent, or where there are questions about moving through the product schedule. Seek urgent medical advice for severe, persistent abdominal pain, a serious allergic reaction, or sudden or worsening eyesight.
What to read next
General information only. Wegovy is a prescription-only medicine. A prescriber decides suitability, dose and monitoring.